Karyopharm Therapeutics

310 articles with Karyopharm Therapeutics

• Karyopharm Initiates STOMP Clinical Trial Of Oral Selinexor In Multiple Myeloma

  10/19/2015

• Karyopharm Advancing Neuroprotective SINE Compounds in Amyotrophic Lateral Sclerosis (ALS)

  9/3/2015

• Karyopharm Tanks After Cancer Drug Trial Patients Get Sepsis

  8/10/2015

• Karyopharm To Report Second Quarter 2015 Financial Results On August 10, 2015

  8/3/2015

• Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At International Conference On Malignant Lymphoma

  6/22/2015

• Karyopharm Presents Hematologic Cancer Data On Lead Drug Candidate Selinexor At European Hematology Association Annual Meeting

  6/15/2015

• ASCO15: Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Recurrent Glioblastoma And Advanced Sarcomas At 2015 ASCO Annual Meeting

  6/1/2015

• ASCO15: Karyopharm Presents Clinical Data For Selinexor (KPT-330) In Patients With Heavily Pretreated Gynecological Cancers And Asian Patients With Advanced Malignancies At 2015 ASCO Annual Meeting

  6/1/2015

• Karyopharm To Present Clinical Data Update For Selinexor (KPT-330) In Solid Tumors

  5/28/2015

• Karyopharm Initiates STORM Clinical Trial Of Oral Selinexor (KPT-330) In Multiple Myeloma

  5/28/2015

• Karyopharm To Present Solid Tumor Data On Lead Drug Candidate Selinexor At 2015 ASCO Annual Meeting

  5/14/2015

• Karyopharm Reports First Quarter 2015 Financial Results And Highlights Recent Progress

  5/11/2015

• Karyopharm To Present At Karyopharm Bank of America 2015 Healthcare Conference

  5/7/2015

• Karyopharm To Report First Quarter 2015 Financial Results On May 11, 2015

  5/5/2015

• Karyopharm Ramps Up Hiring in Anticipation of Seeking Approval for Cancer Drugs

  5/1/2015

• Karyopharm Therapeutics To Present Late-Breaking Data At American Association for Cancer Research Annual Meeting

  4/17/2015

• Karyopharm Therapeutics Granted U.S. Composition-Of-Matter Patent For Selinexor (KPT-330)

  4/13/2015

• Karyopharm Therapeutics To Present Data On Oncology Pipeline At American Association for Cancer Research Annual Meeting

  3/19/2015

• Karyopharm Therapeutics To Present Data On Its Novel Oral PAK4 Allosteric Modulator (PAM) At The American Association for Cancer Research Annual Meeting

  3/19/2015

• Karyopharm Therapeutics Reports Fourth Quarter And Full Year 2014 Financial Results And Highlights Recent Progress

  3/16/2015